Onycholysis associated with paclitaxel

Cutis

Volumn 71, Issue 3, 2003, Pages 229-232

  Mackay Wiggan, Julian ^a   Nair, Kesav G ^b   Halasz, Charles L G ^a  

^a Och Spine at New York Presbyterian Hospitals   (United States)

^b NORWALK HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; AMOXICILLIN PLUS CLAVULANIC ACID; ATORVASTATIN; CARBOPLATIN; CICLOPIROX; DEXAMETHASONE; DILTIAZEM; DIPHENHYDRAMINE; ERYTHROPOIETIN; LATANOPROST; LOSARTAN; PACLITAXEL; PSEUDOMONIC ACID; RANITIDINE; ANTINEOPLASTIC AGENT;

AGED; ARTICLE; BACTERIUM CULTURE; BETA HEMOLYTIC STREPTOCOCCUS; CANCER COMBINATION CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER SURGERY; CANDIDA ALBICANS; CASE REPORT; DERMATOLOGY; DRUG USE; ESCHERICHIA COLI; FUNGUS CULTURE; GLAUCOMA; HUMAN; KIDNEY CARCINOMA; LOW DRUG DOSE; LUNG ADENOCARCINOMA; MALE; NAIL INFECTION; NEPHRECTOMY; ONYCHOLYSIS; STAPHYLOCOCCUS AUREUS; TREATMENT OUTCOME; ADENOCARCINOMA; CHEMICALLY INDUCED DISORDER; HAND DISEASE; LUNG TUMOR; ONYCHOMYCOSIS; PATHOLOGY;

ADENOCARCINOMA; AGED; ANTINEOPLASTIC AGENTS, PHYTOGENIC; HAND DERMATOSES; HUMANS; LUNG NEOPLASMS; MALE; ONYCHOMYCOSIS; PACLITAXEL;

EID: 0038621784     PISSN: 00114162     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (9)

1. Correia O, Azevedo C, Pinto Ferreira E, et al. Nail changes secondary to docetaxel (Taxotere). Dermatology. 1999;198:288-290.
2. Susser WS, Whitaker-Worth DL, Grant-Kels JM. Mucocutaneous reactions to chemotherapy. J Am Acad Dermatol. 1999;40:367-398.
3. Obermair A, Binder M, Barrada M, et al. Onycholysis in patients treated with docetaxel [letter]. Ann Oncol. 1998;9:230-231.
4. Llombart-Cussac A, Pivot X, Spielmann M. Docetaxel therapy induces transverse superficial loss of the nail plate [letter]. Arch Dermatol. 1997;133:1466-1467.
5. Slee PH. Images in clinical medicine, nail changes after chemotherapy. N Engl J Med. 1997;337:168.
6. Flory SM, Solimando DA Jr, Webster Gf, et al. Onycholysis associated with weekly administration of paclitaxel. Ann Pharmacother. 1999;33:584-586.
7. Link CJ Jr, Sarosy GA, Kohn EC, et al. Cutaneous manifestations of Taxol therapy. Invest New Drugs. 1995;13:261-263.
8. Almagro M, Del Pozo J, Garcia-Silva J, et al. Nail alterations secondary to paclitaxel therapy. Eur J Dermatol. 2000;10:146-147.
9. Hussain S, Anderson D, Salvatti ME, et al. Onycholysis as a complication of systemic chemotherapy: report of five cases associated with prolonged weekly paclitaxel therapy and review of the literature. Cancer. 2000;88:2367-2371.